26/05/2026
The British College of Aesthetic Medicine has issued an urgent warning regarding the rapid rise of online injectable peptide promotions.
While peptide therapy is often marketed as a singular, uniform treatment, it actually encompasses a wide range of entirely different compounds with vastly different safety profiles, legal statuses, and clinical backing. While certain evidence-based peptides, like regulated GLP1 receptor antagonists, are safely prescribed within a strict medical framework, they are entirely distinct from the unauthorized, unregulated substances flooding the online market. Purchasing or administering these unverified injectables bypasses crucial regulatory oversight and clinical safety data, exposing individuals to severe and unpredictable health risks. Patient safety must always come first, meaning any injectable therapy should only be pursued following a comprehensive medical consultation, through a valid prescription, and under the direct supervision of a qualified professional in a registered clinical facility.
